News
08 May 2025
Join our Patients Working Group!
Are you living with a rare eye disease? Or are you a caretaker of someone who is? Join the Patients Working Group of the international research project Restore Vision! [Available in EN, IT, ES, FR, SE, DE]
Read more
08 May 2025
New study: mineralocorticoid receptor antagonism improves corneal integrity in a rat model of limbal stem cell deficiency
In this new study, our team at INSERM, explored whether mineralocorticoid receptor antagonists (MRAs)—commonly used for heart and kidney conditions—could aid corneal repair in limbal stem cell deficiency (LSCD), a rare and difficult-to-treat eye disease.
Read more
01 May 2025
New study: the role of Mesenchymal Stromal Cells and Apoptotic Bodies in immune regulation
Research has shown that MSC-derived ApoBDs can help regulate the immune system, however they have not been studied as much as smaller extracellular vesicles. To fill in the gap, our team at Galway conducted a study to explore the therapeutic potential of large and small ApoBDs.
Read more
06 February 2025
Healing the cornea: the therapeutic potential of Mesenchymal Stromal Cells and their Extracellular Vesicles
In this new article, our team at the University of Galway reviewed and analysed current research on the use of MSCs and MSC-EVs in treating corneal diseases.
Read more
30 January 2025
New article: Are inactive ingredients in eye drops safe? A closer look at excipients safety, function an regulation.
Restore Vision has conducted the first comprehensive review of FDA-approved excipients in ophthalmic medications, examining their roles, safety, and the regulatory pathways required for approval for human use.
Read more
17 January 2025
Restore Vision’s first review meeting
On January, 16 the RESTORE VISION team held its first review meeting to assess project progress and discuss plans for the upcoming year.
Read more
11 December 2024
Partecipa al nostro studio presso l’Ospedale San Raffaele di Milano!
Aiutaci a far progredire la ricerca sulle malattie oculari rare!
Read more
11 December 2024
Participate in our study in Milan, Italy!
Join our study in Milan, Italy and help us advance research on rare eye conditions!
Read more
07 November 2024
Restore Vision at EVER 2024
Read more about Restore Vision Special Interest Session at EVER 2024 Congress
Read more
20 October 2024
Restore Vision team participates in DOG 2024 Congress
Last October 10, the Restore Vision team participated in the Deutsche Ophthalmologische Gesellschaft – DOG 2024.
Read more
06 June 2024
Restore Vision 2nd consortium meeting
One year after the project kicked-off, our team met again in-person in Stockholm!
Read more
05 June 2024
Restore Vision partners jointly host the 7th European Anirida Conference
Restore Vision partners participated in 7th European Aniridia Conference.
Read more
12 May 2024
Antisense eye drops only or combined with fine needle diathermy could be used to regress corneal neovascularization in mice – study by UKK
At the recent ARVO meeting, Wei Zhang presented the latest findings from the University of Cologne on a new treatment to regress corneal neovascularization in mice
Read more
12 May 2024
Genetic research shows promise for developing a treatment for the rare eye disease Aniridia – Study by UKK
At the recent ARVO meeting, Karina Hadriaan presented the latest findings from the University of Cologne on a new treatment to regress corneal neovascularization in mice
Read more
12 May 2024
Effectiveness of a new eyedrop in healing wounds on the cornea in rats – Study by INSERM
At the recent ARVO meeting, Daniela Braz presented the latest findings from INSERM on the development of a new eye drop to treat cornea wounds in mice.
Read more
12 May 2024
Exploring the use of spironolactone to treat diseases of the cornea – Study by INSERM
At the recent ARVO meeting, Raquel Gregorio presented the latest findings from INSERM on the use of spironolactone for treating corneal diseases.
Read more
11 May 2024
A novel combination treatment offers promise for corneal vessel regression and longer graft survival – Study by UKK
At the recent ARVO meeting, Meert Mestanoglu presented UKK’s ongoing research on a novel combination treatment for corneal vessel regression.
Read more
10 May 2024
Restore Vision partner KOL hosts Olisens symposium at SFO Congress
Restore Vision partner’s KOL host symposium on SFO 2024 and explored the use of Olisens on the treatment of Corneal Neovessels
Read more
09 May 2024
Restore Vision at ARVO Conference in Seattle
The Restore Vision Consortium had a significant presence at the ARVO 2024 “Vision for the Future” conference from 05th-09th May 2024 in Seattle, Washington to present our work on new therapies for rare ocular diseases.
Read more
08 February 2024
A new eyedrop formulation of spirolactone helps corneal wound healing in rats
Learn more about Restore Vision’s preliminary results on a new eyedrop formulation.
Read more
21 December 2023
Restore Vision’s Ethics Advisor
Restore Vision is thrilled to welcome its new Ethics Advisor, Dr. Helen Busby, who will support the development and review of ethics applications for the project’s research involving human subjects.
Read more
22 September 2023
The start of Restore Vision!
The Restore Vision project has officially started! A consortium of 10 European academic, clinical and enterprise partners led by University of Galway will research and test new treatments for rare eye diseases.
Read more
Interested in Restore vision?
Stay informed about our efforts to combat rare eye diseases and bring new hope to those affected by visual impairment by subscribing to our newsletter for updates on our latest treatments and research.